The wearable pain relief device features the firm’s non-invasive neurostimulation technology that helps in providing relief from chronic pain due to diabetes, sciatica, fibromyalgia, and degenerative knee conditions.

According to the company, the wearable device is lightweight and can be worn during the day while active, and at night while sleeping.

NeuroMetrix president and CEO Shai Gozani said: "Recent studies have shown that chronic nerve pain dramatically reduces the quality of life of people with diabetes. We believe that Quell may help many of these people reclaim their life from chronic pain."

Quell has received FDA approval to treat chronic pain without a prescription, noted NeuroMetrix.

The company plans to make the device available for consumers in the second quarter of 2015.

NeuroMetrix develops wearable medical technology and point-of-care tests for chronic pain, nerve diseases and sleep disorders.

Image: Quell wearable pain relief device. Photo: courtesy of Business Wire.